Osnat Ashur-Fabian
14PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Mar 02, 2024
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer.Adi Alfandari, Dotan Moskovich, Avivit Weisz
|Mar 16, 2023
Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.Dotan Moskovich, Yael Finkelshtein, Adi Alfandari
|Sep 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment.Dotan Moskovich, Yael Finkelshtein, Adi Alfandari
|Sep 17, 2021
Nuclear αvβ3 integrin expression, post translational modifications and regulation in hematological malignancies.Avivit Weisz, Uri Abadi, Lisa Mausbach
|Aug 25, 2021
Pre-diagnosis thyroid hormone dysfunction is associated with cancer mortality.Eilon Krashin, Barbara Silverman, David M Steinberg
Pageof 3